Baseline and early changes in neutrophil-lymphocyte ratio as a prognostic biomarker with 177Lu-PSMA-617 therapy in advanced prostate cancer

Ronit Juthani, Caiwei Zhong, Ali Tarhini, Miguel Muniz, Wanling Xie, Hailey Stoltenberg, Andrew Wolanski, Jolivette Ritzer, Xiao X. Wei, Heather Jacene, Daniel S. Childs, Praful Ravi
Prostate Cancer and Prostatic Diseases · Springer Nature · 2026-11-14 · DOI: 10.1038/s41391-026-01173-w

Abstract

Prostate Cancer and Prostatic Diseases, Published online: 14 November 2026; doi:10.1038/s41391-026-01173-w Baseline and early changes in neutrophil-lymphocyte ratio as a prognostic biomarker with 177 Lu-PSMA-617 therapy in advanced prostate cancer

Read at publisher →

Similar articles